

Blood Substitute Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Blood Substitute market is experiencing significant growth, driven by increasing demand for alternatives to traditional blood products and advancements in biotechnology. The market size is projected to reach approximately $4 billion by 2026, reflecting a CAGR of over 15%. Key factors include rising trauma cases and surgical interventions driving innovation.
◍ Dextro-Sang Corporation
◍ BioPure Corporation
◍ Sangart
◍ Northfield Laboratories
◍ Baxter International
◍ Dentritech
◍ FluorO2 Therapeutics
◍ Nuvox Pharma
◍ Alpha Therapeutic Corporation
◍ HemoBioTech
The blood substitute market features companies like Dextro-Sang Corporation and BioPure Corporation, developing oxygen-carrying solutions. Northfield Laboratories and Sangart focus on synthetic alternatives. Baxter and Alpha Therapeutic offer advanced therapies. These firms drive innovation, expand applications, and increase accessibility, significantly contributing to market growth. Revenue figures vary by company.
Request Sample Report
Hospital
Clinic
Research Institute
Others
Request Sample Report
$ 66.23 Billion
Request Sample Report